1. Home
  2. XNCR vs GES Comparison

XNCR vs GES Comparison

Compare XNCR & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • GES
  • Stock Information
  • Founded
  • XNCR 1997
  • GES 1981
  • Country
  • XNCR United States
  • GES Switzerland
  • Employees
  • XNCR N/A
  • GES N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • GES Apparel
  • Sector
  • XNCR Health Care
  • GES Consumer Discretionary
  • Exchange
  • XNCR Nasdaq
  • GES Nasdaq
  • Market Cap
  • XNCR 1.1B
  • GES 872.4M
  • IPO Year
  • XNCR 2013
  • GES 1996
  • Fundamental
  • Price
  • XNCR $13.86
  • GES $16.98
  • Analyst Decision
  • XNCR Buy
  • GES Buy
  • Analyst Count
  • XNCR 11
  • GES 5
  • Target Price
  • XNCR $24.20
  • GES $19.25
  • AVG Volume (30 Days)
  • XNCR 1.5M
  • GES 572.9K
  • Earning Date
  • XNCR 11-06-2025
  • GES 11-25-2025
  • Dividend Yield
  • XNCR N/A
  • GES 5.30%
  • EPS Growth
  • XNCR N/A
  • GES N/A
  • EPS
  • XNCR N/A
  • GES 0.35
  • Revenue
  • XNCR $146,929,000.00
  • GES $3,091,508,000.00
  • Revenue This Year
  • XNCR $22.09
  • GES $7.97
  • Revenue Next Year
  • XNCR N/A
  • GES $3.46
  • P/E Ratio
  • XNCR N/A
  • GES $48.96
  • Revenue Growth
  • XNCR N/A
  • GES 7.84
  • 52 Week Low
  • XNCR $6.92
  • GES $8.48
  • 52 Week High
  • XNCR $27.24
  • GES $18.07
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 55.63
  • GES 65.47
  • Support Level
  • XNCR $12.17
  • GES $16.75
  • Resistance Level
  • XNCR $15.50
  • GES $17.04
  • Average True Range (ATR)
  • XNCR 1.15
  • GES 0.08
  • MACD
  • XNCR -0.12
  • GES -0.03
  • Stochastic Oscillator
  • XNCR 49.86
  • GES 80.00

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About GES Guess? Inc.

Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.

Share on Social Networks: